                         SEQUENCE LISTING

<110>  UNIVERSITY HEALTH NETWORK
 
<120>  T CELL RECEPTORS AND METHODS OF USE THEREOF

<130>  4285.002PC01/C-K/BMD

<150>  US 62/813,642
<151>  2019-03-04

<160>  62    

<170>  PatentIn version 3.5

<210>  1
<211>  272
<212>  PRT
<213>  Artificial sequence

<220>
<223>  alpha chain amino acid sequence

<400>  1

Met Glu Thr Leu Leu Gly Val Ser Leu Val Ile Leu Trp Leu Gln Leu 
1               5                   10                  15      


Ala Arg Val Asn Ser Gln Gln Gly Glu Glu Asp Pro Gln Ala Leu Ser 
            20                  25                  30          


Ile Gln Glu Gly Glu Asn Ala Thr Met Asn Cys Ser Tyr Lys Thr Ser 
        35                  40                  45              


Ile Asn Asn Leu Gln Trp Tyr Arg Gln Asn Ser Gly Arg Gly Leu Val 
    50                  55                  60                  


His Leu Ile Leu Ile Arg Ser Asn Glu Arg Glu Lys His Ser Gly Arg 
65                  70                  75                  80  


Leu Arg Val Thr Leu Asp Thr Ser Lys Lys Ser Ser Ser Leu Leu Ile 
                85                  90                  95      


Thr Ala Ser Arg Ala Ala Asp Thr Ala Ser Tyr Phe Cys Ala Thr Asp 
            100                 105                 110         


Arg Gly Thr Asp Lys Leu Ile Phe Gly Thr Gly Thr Arg Leu Gln Val 
        115                 120                 125             


Phe Pro Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp 
    130                 135                 140                 


Ser Lys Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser 
145                 150                 155                 160 


Gln Thr Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp 
                165                 170                 175     


Lys Thr Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala 
            180                 185                 190         


Val Ala Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn 
        195                 200                 205             


Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser 
    210                 215                 220                 


Cys Asp Val Lys Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn Leu 
225                 230                 235                 240 


Asn Phe Gln Asn Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu Lys 
                245                 250                 255     


Val Ala Gly Phe Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser Glx 
            260                 265                 270         


<210>  2
<211>  306
<212>  PRT
<213>  Artificial sequence

<220>
<223>  beta chain amino acid sequence

<400>  2

Met Ser Leu Gly Leu Leu Cys Cys Ala Ala Phe Ser Leu Leu Trp Ala 
1               5                   10                  15      


Gly Pro Val Asn Ala Gly Val Thr Gln Thr Pro Lys Phe Arg Val Leu 
            20                  25                  30          


Lys Thr Gly Gln Ser Met Thr Leu Leu Cys Ala Gln Asp Met Asn His 
        35                  40                  45              


Glu Tyr Met Tyr Trp Tyr Arg Gln Asp Pro Gly Met Gly Leu Arg Leu 
    50                  55                  60                  


Ile His Tyr Ser Val Gly Glu Gly Thr Thr Ala Lys Gly Glu Val Pro 
65                  70                  75                  80  


Asp Gly Tyr Asn Val Ser Arg Leu Lys Lys Gln Asn Phe Leu Leu Gly 
                85                  90                  95      


Leu Glu Ser Ala Ala Pro Ser Gln Thr Ser Val Tyr Phe Cys Ala Ser 
            100                 105                 110         


Ser Pro Gly Val Gly Thr Glu Ala Phe Phe Gly Gln Gly Thr Arg Leu 
        115                 120                 125             


Thr Val Val Glu Asp Leu Asn Lys Val Phe Pro Pro Glu Val Ala Val 
    130                 135                 140                 


Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu 
145                 150                 155                 160 


Val Cys Leu Ala Thr Gly Phe Phe Pro Asp His Val Glu Leu Ser Trp 
                165                 170                 175     


Trp Val Asn Gly Lys Glu Val His Ser Gly Val Ser Thr Asp Pro Gln 
            180                 185                 190         


Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys Leu Ser 
        195                 200                 205             


Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His 
    210                 215                 220                 


Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp 
225                 230                 235                 240 


Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala 
                245                 250                 255     


Trp Gly Arg Ala Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln Gln Gly 
            260                 265                 270         


Val Leu Ser Ala Thr Ile Leu Tyr Glu Ile Leu Leu Gly Arg Pro Pro 
        275                 280                 285             


Cys Met Leu Cys Trp Ser Ala Pro Cys Val Asp Gly His Gly Gln Glu 
    290                 295                 300                 


Lys Glx 
305     


<210>  3

<400>  3
000

<210>  4

<400>  4
000

<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  alpha CDR1

<400>  5

Thr Ser Ile Asn Asn 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  alpha CDR2

<400>  6

Met Asn His Glu Tyr 
1               5   


<210>  7
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  alpha CDR3

<400>  7

Cys Ala Thr Asp Arg Gly Thr Asp Lys Leu Ile Phe 
1               5                   10          


<210>  8
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  beta CDR1

<400>  8

Ile Arg Ser Asn Glu Arg Glu 
1               5           


<210>  9
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  beta CDR2

<400>  9

Ser Val Gly Glu Gly Thr 
1               5       


<210>  10
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  beta CDR3

<400>  10

Cys Ala Ser Ser Pro Gly Val Gly Thr Glu Ala Phe Phe 
1               5                   10              


<210>  11

<400>  11
000

<210>  12

<400>  12
000

<210>  13
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  epitope

<400>  13

Glu Phe Thr Val Ser Gly Asn Ile Leu 
1               5                   


<210>  14

<400>  14
000

<210>  15

<400>  15
000

<210>  16
<211>  119
<212>  PRT
<213>  Artificial sequence

<220>
<223>  B2m amino acid sequence

<400>  16

Met Ser Arg Ser Val Ala Leu Ala Val Leu Ala Leu Leu Ser Leu Ser 
1               5                   10                  15      


Gly Leu Glu Ala Ile Gln Arg Thr Pro Lys Ile Gln Val Tyr Ser Arg 
            20                  25                  30          


His Pro Ala Glu Asn Gly Lys Ser Asn Phe Leu Asn Cys Tyr Val Ser 
        35                  40                  45              


Gly Phe His Pro Ser Asp Ile Glu Val Asp Leu Leu Lys Asn Gly Glu 
    50                  55                  60                  


Arg Ile Glu Lys Val Glu His Ser Asp Leu Ser Phe Ser Lys Asp Trp 
65                  70                  75                  80  


Ser Phe Tyr Leu Leu Tyr Tyr Thr Glu Phe Thr Pro Thr Glu Lys Asp 
                85                  90                  95      


Glu Tyr Ala Cys Arg Val Asn His Val Thr Leu Ser Gln Pro Lys Ile 
            100                 105                 110         


Val Lys Trp Asp Arg Asp Met 
        115                 


<210>  17
<211>  816
<212>  DNA
<213>  Artificial sequence

<220>
<223>  alpha chain nucleotide sequence

<400>  17
atggaaactc tcctgggagt gtctttggtg attctatggc ttcaactggc tagggtgaac       60

agtcaacagg gagaagagga tcctcaggcc ttgagcatcc aggagggtga aaatgccacc      120

atgaactgca gttacaaaac tagtataaac aatttacagt ggtatagaca aaattcaggt      180

agaggccttg tccacctaat tttaatacgt tcaaatgaaa gagagaaaca cagtggaaga      240

ttaagagtca cgcttgacac ttccaagaaa agcagttcct tgttgatcac ggcttcccgg      300

gcagcagaca ctgcttctta cttctgtgct acggaccggg gcaccgacaa gctcatcttt      360

gggactggga ccagattaca agtctttcca aatatccaga accctgaccc tgccgtgtac      420

cagctgagag actctaaatc cagtgacaag tctgtctgcc tattcaccga ttttgattct      480

caaacaaatg tgtcacaaag taaggattct gatgtgtata tcacagacaa aactgtgcta      540

gacatgaggt ctatggactt caagagcaac agtgctgtgg cctggagcaa caaatctgac      600

tttgcatgtg caaacgcctt caacaacagc attattccag aagacacctt cttccccagc      660

ccagaaagtt cctgtgatgt caagctggtc gagaaaagct ttgaaacaga tacgaaccta      720

aactttcaaa acctgtcagt gattgggttc cgaatcctcc tcctgaaagt ggccgggttt      780

aatctgctca tgacgctgcg gctgtggtcc agctga                                816


<210>  18
<211>  918
<212>  DNA
<213>  Artificial sequence

<220>
<223>  beta chain nucleotide sequence

<400>  18
atgagcctcg ggctcctgtg ctgtgcagcc ttttctctcc tgtgggcagg tccagtgaat       60

gctggtgtca ctcagacccc aaaattccgg gtcctgaaga caggacagag catgacactg      120

ctgtgtgccc aggatatgaa ccatgaatac atgtactggt atcgacaaga cccaggcatg      180

gggctgaggc tgattcatta ctcagttggt gagggtacaa ctgccaaagg agaggtccct      240

gatggctaca atgtctccag attaaaaaaa cagaatttcc tgctggggtt ggagtcggct      300

gctccctccc aaacatctgt gtacttctgt gccagcagtc ccggggtggg cactgaagct      360

ttctttggac aaggcaccag actcacagtt gtagaggacc tgaacaaggt gttcccaccc      420

gaggtcgctg tgtttgagcc atcagaagca gagatctccc acacccaaaa ggccacactg      480

gtgtgcctgg ccacaggctt cttccctgac cacgtggagc tgagctggtg ggtgaatggg      540

aaggaggtgc acagtggggt cagcacggac ccgcagcccc tcaaggagca gcccgccctc      600

aatgactcca gatactgcct gagcagccgc ctgagggtct cggccacctt ctggcagaac      660

ccccgcaacc acttccgctg tcaagtccag ttctacgggc tctcggagaa tgacgagtgg      720

acccaggata gggccaaacc cgtcacccag atcgtcagcg ccgaggcctg gggtagagca      780

gactgtggct ttacctcggt gtcctaccag caaggggtcc tgtctgccac catcctctat      840

gagatcctgc taggaaggcc accctgtatg ctgtgctggt cagcgccttg tgttgatggc      900

catggtcaag agaaatga                                                    918


<210>  19
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  19

Met Gln Ala Glu Gly Arg Gly Thr Gly Gly Ser Thr Gly Asp Ala Asp 
1               5                   10                  15      


Gly Pro Gly Gly 
            20  


<210>  20
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  20

Arg Gly Thr Gly Gly Ser Thr Gly Asp Ala Asp Gly Pro Gly Gly Pro 
1               5                   10                  15      


Gly Ile Pro Asp 
            20  


<210>  21
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  21

Ser Thr Gly Asp Ala Asp Gly Pro Gly Gly Pro Gly Ile Pro Asp Gly 
1               5                   10                  15      


Pro Gly Gly Asn 
            20  


<210>  22
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  22

Asp Gly Pro Gly Gly Pro Gly Ile Pro Asp Gly Pro Gly Gly Asn Ala 
1               5                   10                  15      


Gly Gly Pro Gly 
            20  


<210>  23
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  23

Pro Gly Ile Pro Asp Gly Pro Gly Gly Asn Ala Gly Gly Pro Gly Glu 
1               5                   10                  15      


Ala Gly Ala Thr 
            20  


<210>  24
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  24

Gly Pro Gly Gly Asn Ala Gly Gly Pro Gly Glu Ala Gly Ala Thr Gly 
1               5                   10                  15      


Gly Arg Gly Pro 
            20  


<210>  25
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  25

Ala Gly Gly Pro Gly Glu Ala Gly Ala Thr Gly Gly Arg Gly Pro Arg 
1               5                   10                  15      


Gly Ala Gly Ala 
            20  


<210>  26
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  26

Glu Ala Gly Ala Thr Gly Gly Arg Gly Pro Arg Gly Ala Gly Ala Ala 
1               5                   10                  15      


Arg Ala Ser Gly 
            20  


<210>  27
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  27

Gly Gly Arg Gly Pro Arg Gly Ala Gly Ala Ala Arg Ala Ser Gly Pro 
1               5                   10                  15      


Gly Gly Gly Ala 
            20  


<210>  28
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  28

Arg Gly Ala Gly Ala Ala Arg Ala Ser Gly Pro Gly Gly Gly Ala Pro 
1               5                   10                  15      


Arg Gly Pro His 
            20  


<210>  29
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  29

Ala Arg Ala Ser Gly Pro Gly Gly Gly Ala Pro Arg Gly Pro His Gly 
1               5                   10                  15      


Gly Ala Ala Ser 
            20  


<210>  30
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  30

Pro Gly Gly Gly Ala Pro Arg Gly Pro His Gly Gly Ala Ala Ser Gly 
1               5                   10                  15      


Leu Asn Gly Cys 
            20  


<210>  31
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  31

Pro Arg Gly Pro His Gly Gly Ala Ala Ser Gly Leu Asn Gly Cys Cys 
1               5                   10                  15      


Arg Cys Gly Ala 
            20  


<210>  32
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  32

Gly Gly Ala Ala Ser Gly Leu Asn Gly Cys Cys Arg Cys Gly Ala Arg 
1               5                   10                  15      


Gly Pro Glu Ser 
            20  


<210>  33
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  33

Gly Leu Asn Gly Cys Cys Arg Cys Gly Ala Arg Gly Pro Glu Ser Arg 
1               5                   10                  15      


Leu Leu Glu Phe 
            20  


<210>  34
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  34

Cys Arg Cys Gly Ala Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe Tyr 
1               5                   10                  15      


Leu Ala Met Pro 
            20  


<210>  35
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  35

Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe 
1               5                   10                  15      


Ala Thr Pro Met 
            20  


<210>  36
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  36

Arg Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu 
1               5                   10                  15      


Ala Glu Leu Ala 
            20  


<210>  37
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  37

Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg 
1               5                   10                  15      


Arg Ser Leu Ala 
            20  


<210>  38
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  38

Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala Gln 
1               5                   10                  15      


Asp Ala Pro Pro 
            20  


<210>  39
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  39

Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala Gln Asp Ala Pro Pro Leu 
1               5                   10                  15      


Pro Val Pro Gly 
            20  


<210>  40
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  40

Arg Arg Ser Leu Ala Gln Asp Ala Pro Pro Leu Pro Val Pro Gly Val 
1               5                   10                  15      


Leu Leu Lys Glu 
            20  


<210>  41
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  41

Gln Asp Ala Pro Pro Leu Pro Val Pro Gly Val Leu Leu Lys Glu Phe 
1               5                   10                  15      


Thr Val Ser Gly 
            20  


<210>  42
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  42

Leu Pro Val Pro Gly Val Leu Leu Lys Glu Phe Thr Val Ser Gly Asn 
1               5                   10                  15      


Ile Leu Thr Ile 
            20  


<210>  43
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  43

Val Leu Leu Lys Glu Phe Thr Val Ser Gly Asn Ile Leu Thr Ile Arg 
1               5                   10                  15      


Leu Thr Ala Ala 
            20  


<210>  44
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  44

Phe Thr Val Ser Gly Asn Ile Leu Thr Ile Arg Leu Thr Ala Ala Asp 
1               5                   10                  15      


His Arg Gln Leu 
            20  


<210>  45
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  45

Asn Ile Leu Thr Ile Arg Leu Thr Ala Ala Asp His Arg Gln Leu Gln 
1               5                   10                  15      


Leu Ser Ile Ser 
            20  


<210>  46
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  46

Arg Leu Thr Ala Ala Asp His Arg Gln Leu Gln Leu Ser Ile Ser Ser 
1               5                   10                  15      


Cys Leu Gln Gln 
            20  


<210>  47
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  47

Asp His Arg Gln Leu Gln Leu Ser Ile Ser Ser Cys Leu Gln Gln Leu 
1               5                   10                  15      


Ser Leu Leu Met 
            20  


<210>  48
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  48

Gln Leu Ser Ile Ser Ser Cys Leu Gln Gln Leu Ser Leu Leu Met Trp 
1               5                   10                  15      


Ile Thr Gln Cys 
            20  


<210>  49
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  49

Ser Cys Leu Gln Gln Leu Ser Leu Leu Met Trp Ile Thr Gln Cys Phe 
1               5                   10                  15      


Leu Pro Val Phe 
            20  


<210>  50
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  50

Leu Ser Leu Leu Met Trp Ile Thr Gln Cys Phe Leu Pro Val Phe Leu 
1               5                   10                  15      


Ala Gln Pro Pro 
            20  


<210>  51
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic Peptide Fragments

<400>  51

Trp Ile Thr Gln Cys Phe Leu Pro Val Phe Leu Ala Gln Pro Pro Ser 
1               5                   10                  15      


Gly Gln Arg Arg 
            20  


<210>  52
<211>  180
<212>  PRT
<213>  Artificial sequence

<220>
<223>  NY-ESO-1 Amino Acid Sequence

<400>  52

Met Gln Ala Glu Gly Arg Gly Thr Gly Gly Ser Thr Gly Asp Ala Asp 
1               5                   10                  15      


Gly Pro Gly Gly Pro Gly Ile Pro Asp Gly Pro Gly Gly Asn Ala Gly 
            20                  25                  30          


Gly Pro Gly Glu Ala Gly Ala Thr Gly Gly Arg Gly Pro Arg Gly Ala 
        35                  40                  45              


Gly Ala Ala Arg Ala Ser Gly Pro Gly Gly Gly Ala Pro Arg Gly Pro 
    50                  55                  60                  


His Gly Gly Ala Ala Ser Gly Leu Asn Gly Cys Cys Arg Cys Gly Ala 
65                  70                  75                  80  


Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe 
                85                  90                  95      


Ala Thr Pro Met Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala Gln Asp 
            100                 105                 110         


Ala Pro Pro Leu Pro Val Pro Gly Val Leu Leu Lys Glu Phe Thr Val 
        115                 120                 125             


Ser Gly Asn Ile Leu Thr Ile Arg Leu Thr Ala Ala Asp His Arg Gln 
    130                 135                 140                 


Leu Gln Leu Ser Ile Ser Ser Cys Leu Gln Gln Leu Ser Leu Leu Met 
145                 150                 155                 160 


Trp Ile Thr Gln Cys Phe Leu Pro Val Phe Leu Ala Gln Pro Pro Ser 
                165                 170                 175     


Gly Gln Arg Arg 
            180 


<210>  53
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA-TCRa-1

<400>  53
guaaggauuc ugauguguat t                                                 21


<210>  54
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA-TCRa-2

<400>  54
uacacaucag aauccuuact t                                                 21


<210>  55
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA-TCRb-1

<400>  55
ccaccauccu cuaugagaut t                                                 21


<210>  56
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA-TCRb-2

<400>  56
aucucauaga ggaugguggt t                                                 21


<210>  57
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  3' TCR alpha untranslated region primer

<400>  57
ggagagttcc ctctgtttgg agag                                              24


<210>  58
<211>  43
<212>  DNA
<213>  Artificial sequence

<220>
<223>  modified 5 RACE primer

<400>  58
gtgtggtggt acgggaattc aagcagtggt atcaacgcag agt                         43


<210>  59
<211>  43
<212>  DNA
<213>  Artificial sequence

<220>
<223>  3' -TCR primer

<400>  59
accactgtgc tggcggccgc tcagctggac cacagccgca gcg                         43


<210>  60
<211>  56
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Beta C region specific reverse primer 3-C Beta-1

<400>  60
atcgtcgacc actgtgctgg cggccgctcg agttccaggg ctgccttcag aaatcc           56


<210>  61
<211>  59
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Beta C region specific reverse primer 3-C Beta-2

<400>  61
gaccactgtg ctggcggccg ctcgagctag cctctggaat cctttctctt gaccattgc        59


<210>  62
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HIV nef92-100

<400>  62

Lys Glu Lys Gly Gly Leu Glu Gly Leu 
1               5                   


